MERSANA THERAPEUTICS INC. - COMMON STOCK
0,5991
18-февраля-25 12:16:16
15 мин. задержка
Акции
+0,0171
+2,94%
Сегодняшний диапазон
0,5936 - 0,6200
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
31 окт 2023 16:30:25 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
31 окт 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Changes in Leadership
06 сен 2023 07:00:40 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
08 авг 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 авг 2023 16:05:52 Источник Nasdaq GlobeNewswire
-
27 июл 2023 07:06:23 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 июл 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
15 июн 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 июн 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
24 май 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
09 май 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 май 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Present at Bank of America Securities 2023 Healthcare Conference
03 май 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host First Quarter 2023 Conference Call on May 9, 2023
02 май 2023 08:00:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Upcoming Presentations at 2023 ASCO Annual Meeting
26 апр 2023 16:05:01 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06 апр 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Clinical Hold on XMT-2056 Phase 1 Clinical Trial
13 мар 2023 07:30:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Provides Statement About SVB
10 мар 2023 19:10:38 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 мар 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
Mersana Therapeutics to Host Fourth Quarter and Year End 2022 Conference Call on February 28, 2023
21 фев 2023 08:00:01 Источник Nasdaq GlobeNewswire